Health Care • Medical/Nursing Services
$60.22 ▲ +0.76
(+1.28%)
MKT CAP: $11.92B • VOL: 3.98M
52W L $31 52W H $74
BTSG // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $12.91B | $10.07B | $7.69B |
| YoY Revenue Growth % | +28.2% | +31.0% | — |
| Gross Profit | $1.52B | $1.27B | $3.38B |
| Gross Margin % | 11.8% | 12.6% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $295.3M | $108.0M | $58.1M |
| Operating Margin % | 2.3% | 1.1% | 0.8% |
| Net Income (GAAP) | $189.1M | $20.5M | -$154.6M |
| EBITDA (Normalized) | $371.6M | $172.7M | $335.0M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $490.2M | $23.8M | $210.8M |
| Capital Expenditures (CapEx) | $95.5M | $80.9M | $346.1M |
| Free Cash Flow (FCF) | $394.7M | -$57.1M | -$135.3M |
| FCF Margin % | 3.1% | -0.6% | -1.8% |
| Return on Invested Capital (ROIC %) | 5.5% | 2.1% | 0.8% |
| Cash & Short-Term Equivalents | $88.4M | $61.0M | $1.02B |
| Total Debt (Short + Long Term) | $2.46B | $2.56B | $2.16B |
| Total Stockholders' Equity | $1.88B | $1.65B | $4.43B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR BTSG.